Roche's (RHHBY) Tecentriq Gets FDA Nod for Another Indication (Revised)

by Zacks Equity Research • October 21, 2021 • 0 Comments

Roche (RHHBY) immuno-oncology drug Tecentriq gets FDA approval for yet another indication of lung cancer.